RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-12.1%
5Y CAGR-49.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-12.1%/yr
vs -50.1%/yr prior
5Y CAGR
-49.4%/yr
Recent acceleration
Acceleration
+38.0pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.90 | -34.3% |
| 2023 | 2.90 | +930.2% |
| 2022 | 0.28 | -90.0% |
| 2021 | 2.80 | -69.4% |
| 2020 | 9.15 | -84.0% |
| 2019 | 57.30 | +86.7% |
| 2018 | 30.70 | -32.1% |
| 2017 | 45.21 | -98.3% |
| 2016 | 2661.81 | -97.2% |
| 2015 | 95148.85 | - |